Amicus Therapeutics Inc (FOLD)
A research Signal Score of unusual activity and the signals behind it. Not advice, not a prediction, not yet backtested.
Our last 30 days of resolved calls came true 29% of the time.See the track record →
Figures reflect the most recent reported period. Margins, ROE and growth are percentages; Debt/Equity and Current ratio are ratios.
A generic 2:1 reward-to-risk example (about a 10% stop and 20% target). Illustrative and educational, not advice. Set your own levels for your risk tolerance.
- 52-week positionBreaking out to new 52-week highs+40
- VolumeNo intraday volume on the free data tier — this factor is disabled, not faked.+0
Score uses live volume/momentum/breakout signals today; insider buying, short interest, options flow and social velocity layer in as those sources come online. How it works →
🤖 Dominant catalyst: none, as the headline is unrelated to company-specific fundamentals. Continuation probability is low-to-moderate, given no direct driver for sustained momentum. Informational only — not financial advice.
- This Hedge Fund Portfolio Shrinks 17% as Billionaire Bets Big on GoldBenzinga · 2026-08-17
Any AI summary is an interpretation of public news, not advice or a price target.